These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30248432)

  • 1. "Polytox" synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux.
    Mayer FP; Schmid D; Holy M; Daws LC; Sitte HH
    Neurochem Int; 2019 Feb; 123():7-12. PubMed ID: 30248432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
    Anneken JH; Angoa-Pérez M; Kuhn DM
    J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.
    Cameron KN; Kolanos R; Solis E; Glennon RA; De Felice LJ
    Br J Pharmacol; 2013 Apr; 168(7):1750-7. PubMed ID: 23170765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.
    Cameron K; Kolanos R; Vekariya R; De Felice L; Glennon RA
    Psychopharmacology (Berl); 2013 Jun; 227(3):493-9. PubMed ID: 23371489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychoactive "bath salts": not so soothing.
    Baumann MH; Partilla JS; Lehner KR
    Eur J Pharmacol; 2013 Jan; 698(1-3):1-5. PubMed ID: 23178799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropharmacology of Synthetic Cathinones.
    Baumann MH; Walters HM; Niello M; Sitte HH
    Handb Exp Pharmacol; 2018; 252():113-142. PubMed ID: 30406443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical binding at dopamine and serotonin transporters contribute to the discriminative stimulus effects of mephedrone.
    DeLarge AF; Erwin LL; Winsauer PJ
    Neuropharmacology; 2017 Jun; 119():62-75. PubMed ID: 28396142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture.
    Harvey EL; Baker LE
    Psychopharmacology (Berl); 2016 Feb; 233(4):673-80. PubMed ID: 26558618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention.
    Glennon RA
    Adv Pharmacol; 2014; 69():581-620. PubMed ID: 24484988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxicology of Synthetic Cathinone Analogs.
    Angoa-Pérez M; Anneken JH; Kuhn DM
    Curr Top Behav Neurosci; 2017; 32():209-230. PubMed ID: 27753008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants.
    Simmons SJ; Leyrer-Jackson JM; Oliver CF; Hicks C; Muschamp JW; Rawls SM; Olive MF
    ACS Chem Neurosci; 2018 Oct; 9(10):2379-2394. PubMed ID: 29714473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical and Cardiovascular Effects of 4-Chloro Ring-Substituted Synthetic Cathinones in Rats.
    Chojnacki MR; Thorndike EB; Partilla JS; Rice KC; Schindler CW; Baumann MH
    J Pharmacol Exp Ther; 2023 Jun; 385(3):162-170. PubMed ID: 36669877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter.
    Gannon BM; Baumann MH; Walther D; Jimenez-Morigosa C; Sulima A; Rice KC; Collins GT
    Neuropsychopharmacology; 2018 Nov; 43(12):2399-2407. PubMed ID: 30305739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones.
    Rickli A; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):365-76. PubMed ID: 25624004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety- and depressant-like effects in cocaine- or MDPV-abstinent rats.
    Philogene-Khalid HL; Hicks C; Reitz AB; Liu-Chen LY; Rawls SM
    Drug Alcohol Depend; 2017 Sep; 178():119-125. PubMed ID: 28646714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mephedrone induces partial release at human dopamine transporters but full release at human serotonin transporters.
    Mayer FP; Niello M; Bulling S; Zhang YW; Li Y; Kudlacek O; Holy M; Kooti F; Sandtner W; Rudnick G; Schmid D; Sitte HH
    Neuropharmacology; 2023 Dec; 240():109704. PubMed ID: 37703919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profile of mephedrone analogs and related new psychoactive substances.
    Luethi D; Kolaczynska KE; Docci L; Krähenbühl S; Hoener MC; Liechti ME
    Neuropharmacology; 2018 May; 134(Pt A):4-12. PubMed ID: 28755886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothesizing that designer drugs containing cathinones ("bath salts") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption.
    Blum K; Foster Olive M; Wang KK; Febo M; Borsten J; Giordano J; Hauser M; Gold MS
    Med Hypotheses; 2013 Sep; 81(3):450-5. PubMed ID: 23845561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters.
    Magee CP; German CL; Siripathane YH; Curtis PS; Anderson DJ; Wilkins DG; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2020 Aug; 374(2):273-282. PubMed ID: 32385092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.